Stock Information
Bio Rad Laboratories Inc (BIO)
Ticker Symbol: BIO
Exchange: NYSE
Sector: Life Sciences Tools & Services
Market Cap: $10,332.92 mil
Piotroski score: 5
PE Ratio: 45.95
EPS (TTM): 8.25
Revenue (TTM): $96.57 M
Dividend Yield: N/A
ROE: 3.15%
Latest News
-
Biodesix Expands MRD Testing With Tumor-Informed and Tumor-Naive Tests
Mon, Sep 28, 2026 2:03 PM
-
Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership
Mon, Sep 28, 2026 8:07 AM
-
Bio-Rad Laboratories Bets on Digital PCR, Margins and Smarter M&A Growth
Sat, Sep 26, 2026 3:02 AM
-
Bio-Rad Laboratories, Inc. (BIO) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum Transcript
Thu, Sep 24, 2026 1:09 PM
-
Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius
Thu, Sep 24, 2026 1:00 PM
-
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher
Thu, Sep 24, 2026 10:34 AM
-
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
Thu, Sep 24, 2026 10:00 AM
-
Here's Why You Should Hold Bio-Rad Stock in Your Portfolio for Now
Wed, Sep 23, 2026 3:22 PM
-
Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share
Wed, Sep 23, 2026 8:11 AM
-
Capitalize on Label-Free Array Systems Disruption: Benchmark Agilent, Cytiva, Sartorius, Bio-Rad and PerkinElmer to Secure R&D ROI and Global Market Share
Tue, Sep 22, 2026 8:31 AM
Key Financials
Financial data not available
